A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in Children With Generalized Myasthenia Gravis (gMG)
Abroad (travel likely)RecruitingPHASE2
Conditions
Generalized Myasthenia Gravis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Austin Neuromuscular Center, Austin, Texas, United States
Hopital Armand Trousseau, Paris, France
Hospital Universitari i Politecnic La Fe, Valencia, Spain
John Radcliffe Hospital, Headington, Oxford, United Kingdom
Study leads
MD
Study Director
Amgen